Hexafluronium bromide
Pharmaceutical drug
- M03AC05 (WHO)
- N,N-di-9H-fluoren-9-yl-N,N,N',N'-tetramethylhexane-1,6-diaminium dibromide
- 317-52-2
N
- 9434
- DB00941
Y
- 9063 Y
- B64NJG83K2
- D04435 Y
- DTXSID6048753
- Interactive image
- [Br-].[Br-].c1cccc3c1c2c(cccc2)C3[N+](CCCCCC[N+](C6c4ccccc4c5ccccc56)(C)C)(C)C
InChI
- InChI=1S/C36H42N2.2BrH/c1-37(2,35-31-21-11-7-17-27(31)28-18-8-12-22-32(28)35)25-15-5-6-16-26-38(3,4)36-33-23-13-9-19-29(33)30-20-10-14-24-34(30)36;;/h7-14,17-24,35-36H,5-6,15-16,25-26H2,1-4H3;2*1H/q+2;;/p-2Y
- Key:WDEFPRUEZRUYNW-UHFFFAOYSA-LY
N
Y (what is this?) (verify)Hexafluronium (or hexafluorenium) is a muscle relaxant.[1] It acts as a nicotinic acetylcholine receptor antagonist.
References
- ^ Baraka A (August 1975). "Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase". British Journal of Anaesthesia. 47 (8): 885–8. doi:10.1093/bja/47.8.885. PMID 1201167.
- v
- t
- e
Skeletal muscle relaxants (M03)
(primarily antinicotinic,
NMJ block)
| Non-depolarizing |
| ||||
|---|---|---|---|---|---|
| Depolarizing |
| ||||
| ACh release inhibitors |
 | This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
